| Names | |
|---|---|
| Systematic IUPAC name (5S,6R,7E,9E,11Z,14Z)-6-({(2R)-2-Amino-3-[(carboxymethyl)amino]-3-oxopropyl}sulfanyl)-5-hydroxyicosa-7,9,11,14-tetraenoic acid | |
| Identifiers | |
3D model (JSmol) | |
| ChEBI | |
| ChEMBL | |
| ChemSpider |
|
| MeSH | Leukotriene+D4 |
| UNII | |
| |
| |
| Properties | |
| C25H40N2O6S | |
| Molar mass | 496.66 g·mol−1 |
Except where otherwise noted, data are given for materials in theirstandard state (at 25 °C [77 °F], 100 kPa). | |
Leukotriene D4 (LTD4) is one of theleukotrienes. Its main function in the body is to induce thecontraction of smooth muscle, resulting inbronchoconstriction andvasoconstriction. It also increasesvascular permeability. LTD4 is released bybasophils. Other leukotrienes that function in a similar manner are leukotrienesC4 andE4. Pharmacological agents that inhibit the function of these leukotrienes areleukotriene receptor antagonists (e.g.,zafirlukast,montelukast) and are useful forasthmatic individuals.[1]

Thisbiochemistry article is astub. You can help Wikipedia byadding missing information. |